| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,867 | 31,679 | 33,458 | 33,399 | | Cost of Revenue | 14,674 | 14,037 | 14,772 | 13,976 | | | Gross Profit | 18,193 | 17,642 | 18,686 | 19,423 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,832 | 3,164 | 3,140 | 3,390 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 8,502 | 8,329 | 9,466 | 9,316 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,859 | 6,149 | 6,080 | 6,717 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8 | 562 | 15 | 11 | | Earnings Before Interest And Taxes | 5,867 | 6,711 | 6,095 | 8,289 | | Interest Expense | 8,667 | 8,706 | 8,213 | 9,176 | | Income Before Tax | (2,800) | (1,995) | (2,118) | (887) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (13) | (27) |
-
| (13) | | | | Net Income From Continuing Ops | (2,773) | (2,022) | (2,118) | (887) | | | Non-recurring Events | | Discontinued Operations | (3) | 13,737 | 2,245 | 91 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,816) | 11,715 | 127 | (796) | | Preferred Stock And Other Adjustments | (1,024) | (1,519) | (1,063) | 1,094 | | | Net Income Applicable To Common Shares | ($3,840) | $10,196 | ($936) | $298 |
|
0.43% Nasdaq 
Income Statement
